• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿路上皮肿瘤的CK20和CK5/6免疫组化染色:一种观点

CK20 and CK5/6 Immunohistochemical Staining of Urothelial Neoplasms: A Perspective.

作者信息

Akhtar Mohammed, Rashid Sameera, Gashir Mohamed Ben, Taha Noheir Mostafa, Al Bozom Issam

机构信息

Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar.

出版信息

Adv Urol. 2020 Nov 4;2020:4920236. doi: 10.1155/2020/4920236. eCollection 2020.

DOI:10.1155/2020/4920236
PMID:33488701
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7803166/
Abstract

Cytokeratins belong to the family of intermediate filaments. They are expressed in a highly specific manner in epithelial cells where they play a crucial role in the integrity and mechanical stability of the cells. Several types of cytokeratins have been described in normal as well as neoplastic urothelium. In the case of urothelial neoplasms expression of CK20 and CK5/6 has been shown in several studies to have diagnostic and prognostic implications. Thus, low-grade urothelial carcinoma manifests CK expression limited to the umbrella cells, while high-grade tumors usually have an expression in the entire thickness of the urothelium except for the basal layer. CK5/6 expression on the other hand is expressed in the basal cells in all low-grade and some high-grade urothelial carcinomas. Diffuse CK20 staining accompanied by loss of CK5/6-positive basal layer is usually associated with aggressive clinical behavior. Double staining of the slides for these cytokeratins may facilitate proper interpretation and correlation.

摘要

细胞角蛋白属于中间丝蛋白家族。它们在上皮细胞中以高度特异性的方式表达,在细胞的完整性和机械稳定性方面发挥着关键作用。在正常以及肿瘤性尿路上皮中已描述了几种类型的细胞角蛋白。在几项研究中已表明,对于尿路上皮肿瘤,细胞角蛋白20(CK20)和细胞角蛋白5/6(CK5/6)的表达具有诊断和预后意义。因此,低级别尿路上皮癌表现为CK表达仅限于伞细胞,而高级别肿瘤通常除基底层外,在尿路上皮的全层均有表达。另一方面,CK5/6表达见于所有低级别和部分高级别尿路上皮癌的基底细胞。弥漫性CK20染色伴CK5/6阳性基底层缺失通常与侵袭性临床行为相关。对这些细胞角蛋白进行玻片双重染色可能有助于正确解读和关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df4a/7803166/1b1ce6cc531b/AU2020-4920236.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df4a/7803166/34db11cf317a/AU2020-4920236.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df4a/7803166/ff0e8629ccc9/AU2020-4920236.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df4a/7803166/312200454221/AU2020-4920236.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df4a/7803166/f377c91bc04c/AU2020-4920236.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df4a/7803166/b410378b97a3/AU2020-4920236.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df4a/7803166/c116bca8d73d/AU2020-4920236.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df4a/7803166/90b65cf08dcd/AU2020-4920236.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df4a/7803166/24c0285654b5/AU2020-4920236.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df4a/7803166/1b1ce6cc531b/AU2020-4920236.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df4a/7803166/34db11cf317a/AU2020-4920236.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df4a/7803166/ff0e8629ccc9/AU2020-4920236.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df4a/7803166/312200454221/AU2020-4920236.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df4a/7803166/f377c91bc04c/AU2020-4920236.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df4a/7803166/b410378b97a3/AU2020-4920236.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df4a/7803166/c116bca8d73d/AU2020-4920236.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df4a/7803166/90b65cf08dcd/AU2020-4920236.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df4a/7803166/24c0285654b5/AU2020-4920236.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df4a/7803166/1b1ce6cc531b/AU2020-4920236.009.jpg

相似文献

1
CK20 and CK5/6 Immunohistochemical Staining of Urothelial Neoplasms: A Perspective.尿路上皮肿瘤的CK20和CK5/6免疫组化染色:一种观点
Adv Urol. 2020 Nov 4;2020:4920236. doi: 10.1155/2020/4920236. eCollection 2020.
2
Utility of cytokeratin 5/6, cytokeratin 20, and p16 in the diagnosis of reactive urothelial atypia and noninvasive component of urothelial neoplasia.细胞角蛋白5/6、细胞角蛋白20和p16在反应性尿路上皮异型增生及尿路上皮肿瘤非侵袭性成分诊断中的应用。
Appl Immunohistochem Mol Morphol. 2012 May;20(3):264-71. doi: 10.1097/PAI.0b013e3182351ed3.
3
Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosis.使用细胞角蛋白20(CK20)和细胞角蛋白5(CK5)进行免疫组织化学亚型分类可识别预后不良的上尿路尿路上皮癌。
PLoS One. 2017 Jun 20;12(6):e0179602. doi: 10.1371/journal.pone.0179602. eCollection 2017.
4
Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53, and CD44 antigens.原位尿路上皮癌与非肿瘤性尿路上皮的鉴别性免疫组化染色:细胞角蛋白20、p53和CD44抗原分析
Am J Surg Pathol. 2001 Aug;25(8):1074-8. doi: 10.1097/00000478-200108000-00013.
5
Flat Intraurothelial Neoplasia Exhibiting Diffuse Immunoreactivity for CD44 and Cytokeratin 5 (Urothelial Stem Cell/Basal Cell Markers): A Variant of Intraurothelial Neoplasia Commonly Associated With Muscle-invasive Urothelial Carcinoma.对CD44和细胞角蛋白5(尿路上皮干细胞/基底细胞标志物)呈弥漫性免疫反应的扁平尿路上皮内瘤变:一种通常与肌层浸润性尿路上皮癌相关的尿路上皮内瘤变变体。
Appl Immunohistochem Mol Morphol. 2017 Aug;25(7):505-512. doi: 10.1097/PAI.0000000000000334.
6
Immunohistochemical staining patterns of Ki-67 and p53 in florid reactive urothelial atypia and urothelial carcinoma in situ demonstrate significant overlap.Ki-67 和 p53 的免疫组化染色模式在增生性反应性尿路上皮异型增生和原位尿路上皮癌中存在显著重叠。
Hum Pathol. 2020 Apr;98:81-88. doi: 10.1016/j.humpath.2020.02.008. Epub 2020 Mar 3.
7
Immunohistochemistry of cytokeratin (CK) 5/6, CD44 and CK20 as prognostic biomarkers of non-muscle-invasive papillary upper tract urothelial carcinoma.免疫组织化学染色分析细胞角蛋白(CK)5/6、CD44 和 CK20 作为非肌肉浸润性乳头状上尿路尿路上皮癌的预后生物标志物。
Histopathology. 2019 Feb;74(3):483-493. doi: 10.1111/his.13763. Epub 2018 Dec 2.
8
Correlation analysis of nuclear morphology, cytokeratin and Ki-67 expression of urothelial carcinoma cells.尿路上皮癌细胞的核形态、细胞角蛋白和Ki-67表达的相关性分析
Pathol Int. 2013 Jun;63(6):311-7. doi: 10.1111/pin.12066.
9
Noninvasive Papillary Basal-like Urothelial Carcinoma: A Subgroup of Urothelial Carcinomas With Immunohistochemical Features of Basal Urothelial Cells Associated With a High Rate of Recurrence and Progression.非侵袭性乳头状基底样尿路上皮癌:具有基底尿路上皮细胞免疫组化特征的尿路上皮癌亚组,与高复发率和进展相关。
Appl Immunohistochem Mol Morphol. 2016 Sep;24(8):575-82. doi: 10.1097/PAI.0000000000000224.
10
Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia.细胞角蛋白20和CD44蛋白表达与WHO/ISUP分级在pTa和pT1乳头状尿路上皮肿瘤中的关系。
Mod Pathol. 2000 Dec;13(12):1315-23. doi: 10.1038/modpathol.3880241.

引用本文的文献

1
Vulvar Adenocarcinoma With Pagetoid Spread: A Case Report.伴派杰样扩散的外阴腺癌:病例报告
Cancer Rep (Hoboken). 2025 Jun;8(6):e70241. doi: 10.1002/cnr2.70241.
2
Short histological kaleidoscope - recent findings in histology. Part IV.简短的组织学万花筒 - 组织学的最新发现。第四部分。
Rom J Morphol Embryol. 2024 Jul-Sep;65(3):377-393. doi: 10.47162/RJME.65.3.01.
3
Up-regulation of systemic and local BDNF in non-allergic Nasal Polyps in China.中国非过敏性鼻息肉中全身及局部脑源性神经营养因子的上调。

本文引用的文献

1
Transcriptional Analysis of Immunohistochemically Defined Subgroups of Non-Muscle-Invasive Papillary High-Grade Upper Tract Urothelial Carcinoma.免疫组织化学定义的非肌肉浸润性高级别上尿路尿路上皮乳头状癌亚组的转录分析。
Int J Mol Sci. 2019 Jan 29;20(3):570. doi: 10.3390/ijms20030570.
2
Variants and new entities of bladder cancer.膀胱癌的变异体和新实体。
Histopathology. 2019 Jan;74(1):77-96. doi: 10.1111/his.13752.
3
mRNA-Expression of and Defines Distinct Prognostic Subgroups of Muscle-Invasive Urothelial Bladder Cancer Correlating with Histological Variants.
Pak J Med Sci. 2024 May-Jun;40(5):939-945. doi: 10.12669/pjms.40.5.7907.
4
Occult urothelial carcinoma with mediastinal metastasis: A case report.隐匿性尿路上皮癌伴纵隔转移:一例报告。
Oncol Lett. 2024 Feb 9;27(4):148. doi: 10.3892/ol.2024.14281. eCollection 2024 Apr.
5
Proliferation and immunohistochemistry for p53, CD25 and CK20 in predicting prognosis of non-muscle invasive papillary urothelial carcinomas.p53、CD25和CK20的增殖及免疫组化在预测非肌层浸润性乳头状尿路上皮癌预后中的应用
PLoS One. 2024 Jan 26;19(1):e0297141. doi: 10.1371/journal.pone.0297141. eCollection 2024.
6
Expression of Basal Compartment and Superficial Markers in Upper Tract Urothelial Carcinoma Associated with Balkan Endemic Nephropathy, a Worldwide Disease.基底室和表面标志物在与巴尔干地方性肾病相关的上尿路尿路上皮癌中的表达,一种全球性疾病。
Biomedicines. 2024 Jan 1;12(1):95. doi: 10.3390/biomedicines12010095.
7
Molecular characterization of plasmacytoid urothelial carcinoma and the impact on treatment implications.浆细胞性尿路上皮癌的分子特征及其对治疗意义的影响。
Cancer Treat Res Commun. 2023;37:100779. doi: 10.1016/j.ctarc.2023.100779. Epub 2023 Nov 17.
8
Diagnostic Significance of Cytokeratin 20 and p53 as Adjunct Immunocytological Markers in Urine Cytology to Detect Urothelial Carcinomas: A Systematic Review Study.细胞角蛋白20和p53作为尿液细胞学辅助免疫细胞标志物在检测尿路上皮癌中的诊断意义:一项系统评价研究
Iran J Pathol. 2023 Summer;18(3):257-269. doi: 10.30699/IJP.2023.1972203.3004. Epub 2023 Jul 16.
9
Role of Cytokeratin 20 as a Predictive and Prognostic Marker in Urothelial Neoplasms.细胞角蛋白20在尿路上皮肿瘤中作为预测和预后标志物的作用。
Cureus. 2022 Nov 17;14(11):e31607. doi: 10.7759/cureus.31607. eCollection 2022 Nov.
10
Multiparametric Classification of Non-Muscle Invasive Papillary Urothelial Neoplasms: Combining Morphological, Phenotypical, and Molecular Features for Improved Risk Stratification.非肌肉浸润性乳头状尿路上皮肿瘤的多参数分类:结合形态学、表型和分子特征进行风险分层。
Int J Mol Sci. 2022 Jul 23;23(15):8133. doi: 10.3390/ijms23158133.
mRNA 表达和定义了与组织学变异相关的肌肉浸润性膀胱癌的预后亚群。
Int J Mol Sci. 2018 Oct 30;19(11):3396. doi: 10.3390/ijms19113396.
4
Cytokeratin 5/6 expression in bladder cancer: association with clinicopathologic parameters and prognosis.细胞角蛋白5/6在膀胱癌中的表达:与临床病理参数及预后的关系
BMC Res Notes. 2018 Mar 27;11(1):207. doi: 10.1186/s13104-018-3319-4.
5
Grading of Urothelial Carcinoma and The New "World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016".尿路上皮癌分级与新的“2016 年世界卫生组织泌尿系统及男性生殖器官肿瘤分类”。
Eur Urol Focus. 2019 May;5(3):457-466. doi: 10.1016/j.euf.2018.01.003. Epub 2018 Jan 20.
6
Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosis.使用细胞角蛋白20(CK20)和细胞角蛋白5(CK5)进行免疫组织化学亚型分类可识别预后不良的上尿路尿路上皮癌。
PLoS One. 2017 Jun 20;12(6):e0179602. doi: 10.1371/journal.pone.0179602. eCollection 2017.
7
A Review of Outcomes for Stage Ta Bladder Tumors.Ta期膀胱肿瘤治疗结果综述
Am J Clin Pathol. 2016 Aug;146(2):215-20. doi: 10.1093/ajcp/aqw103.
8
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours.《2016 年世界卫生组织泌尿系统及男性生殖器官肿瘤分类-第 B 部分:前列腺和膀胱肿瘤》。
Eur Urol. 2016 Jul;70(1):106-119. doi: 10.1016/j.eururo.2016.02.028. Epub 2016 Mar 17.
9
Flat Intraurothelial Neoplasia Exhibiting Diffuse Immunoreactivity for CD44 and Cytokeratin 5 (Urothelial Stem Cell/Basal Cell Markers): A Variant of Intraurothelial Neoplasia Commonly Associated With Muscle-invasive Urothelial Carcinoma.对CD44和细胞角蛋白5(尿路上皮干细胞/基底细胞标志物)呈弥漫性免疫反应的扁平尿路上皮内瘤变:一种通常与肌层浸润性尿路上皮癌相关的尿路上皮内瘤变变体。
Appl Immunohistochem Mol Morphol. 2017 Aug;25(7):505-512. doi: 10.1097/PAI.0000000000000334.
10
Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference.前列腺中免疫组织化学应用的最佳实践建议:国际泌尿病理学会共识会议报告。
Am J Surg Pathol. 2014 Aug;38(8):e6-e19. doi: 10.1097/PAS.0000000000000238.